Treximet patents upheld in U.S. court; Rep calls for hearings on big PBM merger;

@FiercePharma: Gilenya isn't worth the price, NICE says.  Story | Follow @FiercePharma  

> Pozen's patents on the migraine drug Treximet, marketed by GlaxoSmithKline, were upheld in court, blocking generics makers' attempts to sell their own versions until at least 2017. News

> U.S. Rep. John Conyers Jr., is asking for a House Judiciary committee hearing on the proposed $29 billion merger between Express Scripts and Medco Health Solutions. Story

> Nestle is reportedly eyeing the nutritions unit Pfizer has decided to sell or spin off. Item

> India's Dr Reddy's Laboratories is counting on growth in North America to drive sales in the current fiscal year. Article

> The World Health Organization is auditing three Nigerian pharma companies with an eye toward improving their operations enough to prequalify their products. Piece

Biotech News

@FierceBiotech: Dendreon releases death-eaters into biotech sector stocks. News | Follow @FierceBiotech  

@JohnCFierce: South Korea's AnC to open research/manufacturing center in Vermont, plans to hire hundreds. Item | Follow @JohnCFierce

@MaureenFierce: Feds descend on San Diego-based vaccine developer NexBio. Report | Follow @MaureenFierce

> Xconomy: Dendreon has only itself to blame for Provenge fiasco. Story

> Researchers wary as Republicans vow to end ESC support. Details

> Venture group building a $50M fund for new biotech investments. Report

> Pfizer taps UCSD for $50M drug discovery program. News

> Is FDA writing a recipe for the failure of biosimilars in the U.S.? More

> VT officials spotlight foreign financing role for stem cell facility. Article

Biotech IT News

> IOM: U.S. health record surveillance is needed. Report

> Google, Microsoft fight science-citation cyberwar online. Details

> Social network algorithm helps identify protein "communities." More

> "Systems biology" integrates all that's known about disease and humans. Story 

> CliniWorks says award-wining AccelFind finds better patients. News

> Bioclinica continues revenue growth streak. Article

Medical Device News

> U.K. official admits he discussed Porton-M3 battle. Details

> Boston Sci invests $37M in Irish facility. More

> Knees help propel Smith & Nephew to a good Q2. News

> QIAGEN completes second submission of U.S. companion diagnostic. Article

> Quidel gets CE mark for influenza assay. Report

> Medtronic gives Yale $2.5M grant to review Infuse. Story

And Finally... Women who carry a faulty copy of a gene called RAD51D have an almost one in 11 chance of ovarian cancer, scientists said. This marks the most significant ovarian cancer gene discovery in 10 years. Report